Humacyte Expands Leadership Team with Appointment of Shamik Parikh, M.D., as Chief Medical Officer
–Seasoned physician, scientist and life science executive brings expertise in clinical research and development across…
News
Achilles Therapeutics to Present at Upcoming Conferences
LONDON, April 05, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments MONTREAL, April 05, 2022 (GLOBE…
Cullinan Oncology to Participate in Upcoming Virtual Healthcare Conferences
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) a…
NextCure to Present at 21st Annual Needham Virtual Healthcare Conference
BELTSVILLE, Md., April 05, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
MBX Biosciences Appoints Ora Hirsch Pescovitz, M.D., to Board of Directors
CARMEL, Ind., April 05, 2022 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
PepGen Appoints Michelle Mellion, M.D., as Senior Vice President, Head of Clinical Development
Dr. Mellion brings deep experience in neuromuscular disease research and treatment as a biopharma executive,…
Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer
WINNIPEG, Manitoba, April 05, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
Chinook Therapeutics, IgA Nephropathy Foundation and Komodo Health Collaborate to Provide Nephrologists with Support and Information to Help Reduce Barriers to Diagnosis and Care
SEATTLE, April 05, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), the IgA Nephropathy…
Longeveron Expands Executive Leadership Team; Appoints K. Chris Min, M.D., Ph.D. as Chief Medical Officer
Dr. Min will lead global clinical development and regulatory strategy MIAMI, April 05, 2022 (GLOBE…
OpGen Announces Interim Analysis Results from Clinical Trial for Unyvero Urinary Tract Infection Panel
Interim analysis performed with initial 150 U.S. patient samples enrolled in its prospective multicenter trial…
Radius Provides Agenda for Today’s R&D Webcast
Focus: RAD011, an investigational synthetic cannabidiol oral solution Webcast details: 10:00am to 12:00pm for current…
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology…
Avicanna Expands its Derma-Cosmetics Brand Pura H&W™ into the European Union through a Partnership with Bio-Gate AG
Brand Pura H&W™ Brand Pura H&W™ The exclusive distribution agreement includes 5 SKUs from Pura…
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
LTX-315’s novel mechanism of action directly targets cancerous skin cells to induce an anti-tumor immune…
Mindset Pharma to Participate in Upcoming Conferences in April 2022
TORONTO, April 05, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Pharma Two B Presents Late-Breaker Abstract on Positive Efficacy and Safety Data of P2B001 from Phase 3 Trial at American Academy of Neurology (AAN) Annual Meeting
REHOVOT, Israel, April 05, 2022 (GLOBE NEWSWIRE) — Pharma Two B Ltd., a privately held…
March Total Bankruptcy Filings Increase 34 Percent from Previous Month
Bankruptcy Trend Still Unclear as First Quarter Filings Down 17 Percent from 2021 NEW YORK,…
Sumo Logic Defines Future of Agent Collection on OpenTelemetry
Open standards approach simplifies data collection across modern application stacks REDWOOD CITY, Calif., April 05,…
Pax8 and Check Point Software Technologies Announce Agreement to Offer Cloud-Based Email Security Solutions
DENVER, April 05, 2022 (GLOBE NEWSWIRE) — Pax8, the best place for IT professionals to…